Disease severity, treatment, demographics and the risk of hospitalization in RA.

被引：0
|
作者：
Wolfe, F
Messer, J
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2001年 / 44卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1956
引用
收藏
页码：S379 / S379
页数：1
相关论文
共 50 条
  • [1] Hydroxychloroquine reduces diabetes risk in RA.
    Wasko, M. C.
    Luggen, M.
    Sibley, J.
    Lingala, B.
    Ward, M.
    Fries, J. F.
    Hubert, H. B.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S785 - S786
  • [2] Risk factors for carotid atherosclerosis in RA.
    Waskol, MC
    Schott, L
    Kao, A
    Cunningham, A
    Morel, P
    Kuller, L
    Tracy, R
    Sutton-Tyrrell, K
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S296 - S297
  • [3] Detrimental Impact Of Long-Term Cumulative Burden Of Rheumatoid Arthritis (RA) Disease Severity On Cardiovascular Outcomes In RA.
    Myasoedova, Elena
    Ilhan, Birkan
    Khun, Helen
    Matteson, Eric L.
    Crowson, Cynthia S.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S159 - S159
  • [4] Influence of sex and shared epitope status on the severity of familial RA.
    Jawaheer, D
    Lum, RF
    Amos, CI
    Gregersen, PK
    Criswell, LA
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S99 - S99
  • [5] The prevalence and impact of managed care in the treatment of RA.
    Yelin, E
    Katz, P
    Sonneborn, D
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S139 - S139
  • [6] A highly active disease, treatment with glucocorticoids or coxibs but not the treatment with TNF inhibitors were identified as risk factors for a cardiac failure in RA.
    Strangfeld, Anja
    Listing, Joachim
    Rau, Rolf
    Kamenz, Ulrike
    Stoyanova-Scholz, Maria
    Babinsky, Karin
    Zink, Angela
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S548 - S548
  • [7] Social impact of disease, disability, and depressive symptoms in RA.
    Katz, Patricia
    Morris, Anne
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S795 - S795
  • [8] Arthritis antigen microarray analysis reveals associations of distinct autoantibody profiles with markers of disease activity and severity in RA.
    Hueber, W
    Kidd, B
    Lee, BJ
    Genovese, M
    Bruce, B
    Fries, J
    van Venrooij, W
    Robinson, WH
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S651 - S651
  • [9] Diagnoses of major depression and the future risk of pain and fatigue in RA.
    Fifield, J
    Tennen, H
    Reisine, S
    McQuillan, J
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1410 - 1410
  • [10] Development of a novel dual TACE/MMP inhibitor for treatment of RA.
    Zhang, YH
    Levin, J
    Xu, J
    Hegen, M
    Keith, J
    Li, GD
    Robertshaw, H
    Brennan, F
    Feldmann, M
    Nickerson-Nutter, C
    Kohlbrenner, M
    Gibbons, J
    Larsen, G
    Lin, LL
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S136 - S136
12345